Healthpeak Properties, Inc. PEAK
Institutional shares held
652 Million
1.57M
calls
260K
puts
Total value of holdings
$12.4B
$29.8M
calls
$4.93M
puts
Market Cap
$10.2B
539,580,992
Shares Out.
Institutional ownership
120.75%
# of Institutions
810
We take great care to ensure that the data presented and summarized in this overview for HEALTHPEAK PROPERTIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PEAK
View all-
Vanguard Group Inc Valley Forge, PA111MShares$2.11 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY77MShares$1.46 Billion0.03% of portfolio
-
State Street Corp Boston, MA48.6MShares$922 Million0.04% of portfolio
-
Principal Financial Group Inc Des Moines, IA27.9MShares$529 Million0.3% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA23.1MShares$439 Million1.63% of portfolio
-
Invesco Ltd. Atlanta, GA21.3MShares$404 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA19.1MShares$362 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY16.5MShares$313 Million0.02% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA14.8MShares$280 Million2.99% of portfolio
-
Morgan Stanley New York, NY13.1MShares$248 Million0.02% of portfolio
Latest Institutional Activity in PEAK
Top Purchases
Top Sells
About PEAK
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Insider Transactions at PEAK
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2025
|
John T Thomas Director |
BUY
Open market or private purchase
|
Direct |
1,450
+0.18%
|
$24,650
$17.05 P/Share
|
|
Aug 04
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
1,490
+0.7%
|
$23,840
$16.83 P/Share
|
|
Jul 31
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
2,930
+1.37%
|
$49,810
$17.06 P/Share
|
|
Jul 28
2025
|
John T Thomas Director |
SELL
Bona fide gift
|
Direct |
5,000
-0.61%
|
-
|
|
Jul 28
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
2,873
+1.37%
|
$48,841
$17.4 P/Share
|
|
May 28
2025
|
Tommy G Thompson Director |
BUY
Open market or private purchase
|
Direct |
5,777
+3.85%
|
$98,209
$17.27 P/Share
|
|
May 09
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
2,750
+1.33%
|
$46,750
$17.39 P/Share
|
|
May 09
2025
|
Tommy G Thompson Director |
BUY
Open market or private purchase
|
Direct |
5,700
+3.95%
|
$96,900
$17.36 P/Share
|
|
Apr 29
2025
|
Ava Lias Booker Director |
BUY
Open market or private purchase
|
Direct |
5,000
+12.33%
|
$85,000
$17.83 P/Share
|
|
Apr 28
2025
|
John T Thomas Director |
BUY
Open market or private purchase
|
Direct |
4,200
+0.51%
|
$71,400
$17.84 P/Share
|
|
Apr 28
2025
|
Pamela Shelley Kessler Director |
BUY
Open market or private purchase
|
Indirect |
2,838
+36.53%
|
$48,246
$17.62 P/Share
|
|
Apr 28
2025
|
Sara Grootwassink Lewis Director |
BUY
Open market or private purchase
|
Indirect |
6,000
+40.0%
|
$102,000
$17.66 P/Share
|
|
Apr 28
2025
|
Katherine M Sandstrom Director |
BUY
Open market or private purchase
|
Direct |
11,288
+16.71%
|
$191,896
$17.65 P/Share
|
|
Apr 28
2025
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
11,337
+5.32%
|
$192,729
$17.68 P/Share
|
|
Apr 25
2025
|
R Kent Griffin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,657
+11.7%
|
-
|
|
Apr 25
2025
|
Sara Grootwassink Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,657
+18.57%
|
-
|
|
Apr 25
2025
|
Ava Lias Booker Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,657
+25.86%
|
-
|
|
Apr 25
2025
|
Katherine M Sandstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,657
+13.74%
|
-
|
|
Apr 25
2025
|
Pamela Shelley Kessler Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,657
+17.48%
|
-
|
|
Apr 25
2025
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,657
+7.43%
|
-
|
Last 12 Months Summary
Buy / Acquisition
187K
Shares
From
18
Insiders
| Grant, award, or other acquisition | 123K shares |
|---|---|
| Open market or private purchase | 63.6K shares |
Sell / Disposition
75.6K
Shares
From
5
Insiders
| Payment of exercise price or tax liability | 15.3K shares |
|---|---|
| Bona fide gift | 60.3K shares |